| Control group (Ctrl) | CPT treatment | HFCWO treatment | Difference between after and before | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Before | After | Before | After | Before | After | CPT | HFCWO | HFCWO | ||||||
 | vs Ctrl | vs Ctrl | vs CPT | ||||||||||||
 | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | Mean | SD | P-value (covariance analysis) | ||
TCCx 106/mg | 9891 | 1797.3 | 10517 | 2514.9 | 9.636 | 3.181 | 8.490. | 2.771 | 9.671 | 2.136 | 7.225 | 1.186 | 0.001 | 0.001 | 0.096 |
Neutroph % | 70.54 | 5.5 | 78.09 | 6.8 | 65.3 | 10.1 | 62.0 | 9.9 | 72.5 | 9.2 | 59.9 | 10.1 | 0.001 | 0.001 | 0.002 |
Lymphoc % | 9.11 | 3.6 | 7.17 | 2.7 | 11.3 | 4.8 | 13.5 | 3.9 | 10.2 | 5.2 | 11.9 | 4.9 | 0.001 | 0.001 | 0.548 |
Eosin % | 1.09 | 0.46 | 0.97 | 0.44 | 0.9 | 0.4 | 0.7 | 0.4 | 0.6 | 0.2 | 0.6 | 0.1 | 0.7 | 0.5 | 0.333 |
Macroph % | 37.2 | 7.8 | 32.2 | 10.8 | 26.9 | 8.5 | 31.2 | 7.5 | 19.9 | 11.1 | 35.6 | 15.2 | 0.03 | 0.001 | 0.012 |
Sputum (ml) | 74.0 | 10.7 | 77.0 | 10.6 | 70.0 | 21.1 | 62.5 | 18.9 | 72.5 | 23.9 | 52.0 | 16.9 | 0.04 | 0.001 | 0.01 |